These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17899094)

  • 1. The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.
    Torres-Carrillo NM; Torres-Carrillo N; Vázquez-Del Mercado M; Delgado-Rizo V; Oregón-Romero E; Parra-Rojas I; Muñoz-Valle JF
    Rheumatol Int; 2008 Feb; 28(4):355-60. PubMed ID: 17899094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism.
    Muñoz-Valle JF; Ruiz-Quezada SL; Oregón-Romero E; Navarro-Hernández RE; Castañeda-Saucedo E; De la Cruz-Mosso U; Illades-Aguiar B; Leyva-Vázquez MA; Castro-Alarcón N; Parra-Rojas I
    Rheumatol Int; 2012 Dec; 32(12):3951-6. PubMed ID: 22200807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha.
    Oregón-Romero E; Vázquez-Del Mercado M; Ruiz-Quezada SL; Navarro-Hernández RE; Rangel-Villalobos H; Martínez-Bonilla G; Bernard-Medina AG; Armendáriz-Borunda J; García-Bañuelos J; Muñoz-Valle JF
    J Investig Med; 2008 Oct; 56(7):937-43. PubMed ID: 18797411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.
    Torres-Carrillo N; Torres-Carrillo NM; Martínez-Bonilla GE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Oregón-Romero E; Bernard-Medina AG; Rangel-Villalobos H; Muñoz-Valle JF
    Clin Exp Med; 2009 Sep; 9(3):223-8. PubMed ID: 19238514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.
    Reyes-Castillo Z; Pereira-Suárez AL; Palafox-Sanchez CA; Rangel-Villalobos H; Estrada-Chávez C; Oregón-Romero E; Angel-Chávez LI; Muñoz-Barrios S; Bueno-Topete MR; Muñoz-Valle JF
    Gene; 2013 Aug; 525(1):130-5. PubMed ID: 23660301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
    Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
    Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
    Gilabert-Estellés J; Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A
    Thromb Res; 2012 Aug; 130(2):242-7. PubMed ID: 22055623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype.
    Ramírez-Pérez S; De la Cruz-Mosso U; Hernández-Bello J; Martínez-Bonilla GE; Ramírez-Dueñas MG; Pereira-Suárez AL; Parra Rojas I; Martínez-López E; Macías-Barragán J; Muñoz-Valle JF
    Autoimmunity; 2017 Dec; 50(8):468-475. PubMed ID: 29226727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.
    Torres-Carrillo N; Magdalena Torres-Carrillo N; Vázquez-Del Mercado M; Rangel-Villalobos H; Parra-Rojas I; Sánchez-Enríquez S; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):220-6. PubMed ID: 18263635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels.
    Navarro-Zarza JE; Muñoz-Valle JF; Baños-Hernández CJ; Parra-Rojas I; Reyes-Castillo Z; Rangel-Villalobos H; Hernández-Bello J
    Clin Rheumatol; 2019 Aug; 38(8):2089-2097. PubMed ID: 30911943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3'-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression.
    Román-Fernández IV; Sánchez-Zuno GA; Padilla-Gutiérrez JR; Cerpa-Cruz S; Hernández-Bello J; Valle Y; Ramírez-Dueñas MG; Carrillo C; Muñoz-Valle JF
    Clin Rheumatol; 2018 Feb; 37(2):345-353. PubMed ID: 28963582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H; Wallmark K; Jern S; Karlsson L
    Thromb Res; 2008; 121(6):793-7. PubMed ID: 17884148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
    Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of angiotensin converting enzyme insertion/deletion gene polymorphism among an Egyptian cohort of patients with rheumatoid arthritis.
    Ahmed AZ; El-Shahaly HA; Omar AS; Ghattas MH
    Int J Rheum Dis; 2013 Jun; 16(3):284-90. PubMed ID: 23981749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-3 gene polymorphism and its mRNA expression in rheumatoid arthritis.
    Ma MJ; Liu HC; Qu XQ; Wang JL
    Genet Mol Res; 2015 Dec; 14(4):15652-9. PubMed ID: 26634533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F11R mRNA expression and promoter polymorphisms in patients with rheumatoid arthritis.
    Fang TJ; Lin CH; Lin YZ; Li RN; Ou TT; Wu CC; Tsai WC; Yen JH
    Int J Rheum Dis; 2016 Feb; 19(2):127-33. PubMed ID: 26230081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.